Related Experiment Videos
The antischistosomal activity of oltipraz
Research Communications in Chemical Pathology and Pharmacology
|August 1, 1982
Summary
Oltipraz effectively eliminates Schistosoma mansoni parasites in mice over two months. Its efficacy is influenced by drug metabolism and can be enhanced with L-cysteine, highlighting structural requirements for dithiolthiones.
Area of Science:
- Pharmacology
- Parasitology
- Drug Discovery
Background:
- Schistosomiasis mansoni remains a significant global health concern.
- Developing effective and safe treatments is crucial for disease control.
Purpose of the Study:
- To evaluate the efficacy of oltipraz as a schistosomicidal agent.
- To investigate factors influencing oltipraz's antischistosomal activity.
Main Methods:
- Administration of a single oral dose of oltipraz to infected mice.
- Assessment of parasite elimination and drug effects over time.
- Investigation of drug metabolism modulation (phenobarbital, BHA) and synergistic agents (L-cysteine).
Main Results:
- Oltipraz demonstrated a slow-acting but complete elimination of Schistosoma mansoni.
- Drug metabolism stimulation reduced oltipraz's efficacy, while L-cysteine enhanced it.
- Early drug effect involves depletion of worm glutathione stores.
Conclusions:
- Oltipraz is a potent schistosomicidal agent with a notable mechanism of action.
- Drug metabolism and co-administration of L-cysteine are critical factors for optimizing oltipraz therapy.
- Structural modifications of dithiolthiones may be necessary for enhanced antischistosomal activity.